会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COLLABORATIVE SEARCHING
    • 合作搜索
    • WO2010075020A2
    • 2010-07-01
    • PCT/US2009067822
    • 2009-12-14
    • MOTOROLA INCMOK SWEE MALBERTH WILLIAM PBARR JOHN RENGELSMA JONATHAN RGILLIG STEVEN FXU XIANG
    • MOK SWEE MALBERTH WILLIAM PBARR JOHN RENGELSMA JONATHAN RGILLIG STEVEN FXU XIANG
    • G06F17/30H04B1/40
    • G06F17/30867G06F17/30678G06F17/30702
    • Disclosed are techniques that allow users (102, 104, 106) to collaborate in a search. Each user (102, 104, 106) can contribute (300, 400) to an original search and to refining (304, 410) the results of the search. Preferences of all of the users (102, 104, 106) are considered (308, 402) in the search even while those preferences can be kept private. In some embodiments of the present invention, at least two users (102, 104, 106) each submit (300, 304) a search query. The multiple search queries are logically combined (306) to produce (310) one set of search results. The results can be reviewed by the users (102, 104, 106) and refined (304) if necessary. In some embodiments, a search query can be specified (400) by a single user (102, 104, 106), but the search engine takes into consideration (402) the stored preferences of multiple users (102, 104, 106) (in addition to the search query itself, of course).
    • 公开了允许用户(102,104,106)在搜索中合作的技术。 每个用户(102,104,106)可以贡献(300,400)到原始搜索并且精炼(304,410)搜索结果。 在搜索中考虑所有用户(102,104,106)的偏好(308,402),即使这些偏好可以保持私密。 在本发明的一些实施例中,至少两个用户(102,104,106)各自提交(300,304)搜索查询。 多个搜索查询在逻辑上组合(306)以产生(310)一组搜索结果。 如果有必要,结果可以由用户(102,104,106)查看并且精炼(304)。 在一些实施例中,搜索查询可以由单个用户(102,104,106)指定(400),但是搜索引擎考虑(402)多个用户(102,104,106)的存储的偏好(在 当然,除了搜索查询本身之外)。
    • 5. 发明申请
    • DETECTION OF ADENYLATE CYCLASE
    • 检测腺苷酸环化酶
    • WO2012074683A2
    • 2012-06-07
    • PCT/US2011059739
    • 2011-11-08
    • US GOV HEALTH & HUMAN SERVBOYER ANNE ELINS RENATO CKUKLENYIK ZSUZSANNAGALLEGOS-CANDELA MARIBELQUINN CONRAD PBARR JOHN R
    • BOYER ANNE ELINS RENATO CKUKLENYIK ZSUZSANNAGALLEGOS-CANDELA MARIBELQUINN CONRAD PBARR JOHN R
    • G01N33/56911C12Q1/527G01N2333/32G01N2333/988
    • One major problem in diagnosis methods presently available for anthrax is that these methods require several days to produce a result, are rendered unusable after antibiotic use, or are not quantifiable. The only existing treatment for anthrax requires administration soon after infection at a time when patients are exhibiting only mild flu-like symptoms. Thus, by the time a diagnosis is made a patient may be days beyond the time when treatment would be effective. The present invention reduces diagnosis time to as little as four hours providing same day identification of anthrax radically increasing the odds of delivering proper treatment and patient recovery. The rapid identification of anthrax edema factor activity exhibited by the invention is also amenable to in vivo screening protocols for the discovery and development of anthrax vaccines, anti-toxins and edema factor inhibitors. The invention isolates and concentrates edema factor and edema toxin from nearly any sample. By capitalizing on the adenylate cyclase activity of edema factor the invention amplifies output signals producing reliable detection of low concentrations of edema factor previously unachievable. The invention involves novel purification and detection techniques and substrates for rapid, reproducible, and quantitative measurements of anthrax edema factor, and other adenylate cyclases in biological samples.
    • 目前可用于炭疽的诊断方法中的一个主要问题是这些方法需要几天才能产生结果,在抗生素使用后不能使用,或不能量化。 炭疽病唯一现有的治疗方法需要在感染后立即进行治疗,当时患者只出现轻微的流感样症状。 因此,在进行诊断的时候,患者可以是治疗有效的时间。 本发明将诊断时间缩短至少于4小时,同时提供炭疽的同一天鉴定,从而大大增加了提供适当治疗和患者恢复的几率。 本发明显示的炭疽水肿因子活性的快速鉴定也适用于发现和发展炭疽疫苗,抗毒素和水肿因子抑制剂的体内筛选方案。 本发明从几乎任何样品中分离并浓缩水肿因子和水肿毒素。 通过利用水肿因子的腺苷酸环化酶活性,本发明放大了产生可靠检测低浓度水肿因子的输出信号,这是先前无法实现的。 本发明涉及用于快速,可重复和定量测量生物样品中炭疽水肿因子和其他腺苷酸环化酶的新型纯化和检测技术和底物。
    • 6. 发明申请
    • DETECTION OF ANTHRAX PATHOGENICITY FACTORS
    • 检测ANTHRAX致病因子
    • WO2007136436A3
    • 2008-07-24
    • PCT/US2007004156
    • 2007-02-15
    • US GOV HEALTH & HUMAN SERVBOYER ANNE EQUINN CONRAD PBARR JOHN R
    • BOYER ANNE EQUINN CONRAD PBARR JOHN R
    • C12Q1/00C12N9/00
    • G01N33/56911G01N2333/32G01N2500/00
    • One major problem in diagnosis methods presently available for anthrax is that these methods require several days to produce a result. The only existing treatment for anthrax requires administration soon after infection at a time when patients are exhibiting only mild flu- like symptoms. Thus, a patient may be days beyond the time when treatment would be effective by the time a diagnosis is made. The present invention reduces diagnosis time to as little as four hours providing same day identification of anthrax radically increasing the odds of delivering proper treatment and patient recovery. The rapid identification of anthrax lethal factor activity exhibited by the instant invention is also amenable to in vivo screening protocols for the discovery and development of anthrax vaccines and lethal factor inhibitors. The instant invention isolates and concentrates lethal factor and lethal toxin from nearly any biological sample. By capitalizing on the endopeptidase activity of lethal factor the present invention amplifies output signals producing reliable detection of picomolar concentrations of lethal factor. The instant invention involves novel purification and detection techniques and substrates for rapid, reproducible, and quantitative measurements of anthrax lethal factor in biological samples.
    • 目前可用于炭疽的诊断方法的一个主要问题是这些方法需要几天才能产生结果。 炭疽病唯一现有的治疗方法需要在感染后立即进行治疗,当时患者仅出现轻微的流感样症状。 因此,患者可能是在诊断时治疗有效的时间。 本发明将诊断时间缩短至少于4小时,同时提供炭疽的同一天鉴定,从而大大增加了提供适当治疗和患者恢复的几率。 本发明显示的炭疽致死因子活性的快速鉴定也适用于发现和发展炭疽疫苗和致死因子抑制剂的体内筛选方案。 本发明从几乎任何生物样品中分离和浓缩致死因子和致死毒素。 通过利用致死因子的内肽酶活性,本发明扩增了产生对皮摩尔浓度致死因子的可靠检测的输出信号。 本发明涉及用于生物样品中炭疽致死因子的快速,可重复和定量测量的新颖的纯化和检测技术和底物。